Status:
COMPLETED
Supporting Trans Affirmation, Relationships, and Sex, Phase 3
Lead Sponsor:
Brown University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
The University of Akron
Conditions:
HIV
Violence, Gender-Based
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
The purpose of this clinical trial is to evaluate and test a newly developed gender-affirming intervention that addresses the dual and interconnected risks of HIV and intimate partner victimization (I...
Detailed Description
Transgender women (TW) are among the populations most heavily affected by HIV in the United States (US), with nearly 1 in 5 TW living with HIV. The risk for HIV in TW often occurs in the context of in...
Eligibility Criteria
Inclusion
- 18+ years old;
- Assigned male at birth but identify as female, transgender, or transfeminine;
- Endorse at least one IPV incident during the previous 12 months based on the trans-specific IPV Scale (T-IPV Scale; Peitzmeier et al, in press);
- Report at least one instance of condomless anal sex in the last 6 months.
Exclusion
- Have been diagnosed with HIV or test positive for HIV.
Key Trial Info
Start Date :
June 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT06001307
Start Date
June 20 2023
End Date
May 30 2024
Last Update
November 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brown University
Providence, Rhode Island, United States, 02912